肝细胞腺瘤Gd-EOB-DTPA MRI增强诊断（附2例报告并文献复习）

摘要
图/表
参考文献
相关文章 (1)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：探讨肝腺瘤Gd-EOB-DTPA增强表现。材料和方法：对行Gd-EOB-DTPA增强扫描的经病理学证实为肝腺瘤的2例病人的MRI表现进行回顾性分析，并复习相关文献。结果：1例为单发，1例为多发病变。动脉期均有中度以上强化，静脉期持续强化。肝细胞期与周围的肝组织相比，1例表现为等高信号，1例表现为低信号。结论：肝细胞腺瘤Gd-EOB-DTPA动态强化形式与细胞外对比剂增强类似，肝胆期可呈相对低信号或等高信号。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	唐敏
	陈骏
	韩鹏
	张庆雷
	何健
	仇毓东
	窦鑫
	朱斌

关键词 ：腺瘤, 肝细胞；磁共振成像

收稿日期: 2016-12-05

PACS:	Ｒ735.7
	Ｒ445.2

通讯作者: 朱斌，南京鼓楼医院放射科，210008。E-mail：gobincdr@163.com

作者简介: 唐敏（1983-），女，江苏连云港人，主治医师。E-mail：3012584273@qq.com

引用本文:

唐敏，陈骏，韩鹏，张庆雷，何健，仇毓东，窦鑫，朱斌. 肝细胞腺瘤Gd-EOB-DTPA MRI增强诊断（附2例报告并文献复习）[J]. 中国临床医学影像杂志, 2017, 28(12): 899-902.
TANG Min, CHEN Jun, HAN Peng, ZHANG Qing-lei, HE Jian, QIU Yu-dong, DOU Xin, ZHU Bin. Diagnosis of hepatocellular adenomas on gadoxetic acid-enhanced MRI（report of 2 cases and review of literature）. JOURNAL OF CHINA MEDICAL IMAGING, 2017, 28(12): 899-902.

链接本文:

http://www.jccmi.com.cn/CN/ 或 http://www.jccmi.com.cn/CN/Y2017/V28/I12/899

[1]唐晓艳，陈萌，马明圣，等. 82例糖原累积症Ⅰa型肝脏受累特点[J]. 协和医学杂志，2014，5（4）：405-407.
[2]Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC[J]. Hepatology, 2006, 43(3)： 515-524.
[3]van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification[J]. Radiology, 2011, 261(1): 172-181.
[4]Takara K, Saito K, Kusama H, et al. Gd-EOB-DTPA-enhanced MR imaging findings of hepatocellular adenoma: correlation with pathological findings[J]. Magn Reson Med Sci, 2011, 10(4): 245-249.
[5]Denecke T, Steffen IG, Agarwal S, et al. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI[J]. Eur Radiol, 2012, 22(8): 1769-1775.
[6]Yoneda N, Matsui O, Kitao A, et al. Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8[J]. Jpn J Radiol, 2012, 30(9): 777-782.
[7]Grieser C, Steffen IG, Kramme IB, et al. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience[J]. Eur Radiol, 2014, 24(6): 1339-1348.
[8]Grazioli L, Morana G, Kirchin MA, et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study[J]. Radiology, 2005, 236(1): 166-177.
[9]Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging—correlation with molecular transporters and histopathologic features[J]. Radiology, 2010, 256(3): 817-826.
[10]Vander Borght S, Libbrecht L, Blokzijl H, et al. Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver[J]. J Pathol, 2005, 207(4): 471-482.
[11]Ba-Ssalamah A, Antunes C, Feier D, et al. Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging[J]. Radiology, 2015, 277(1): 104-113.
[12]Agarwal S, Fuentes-Orrego JM, Arnason T, et al. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI[J]. AJR, 2014, 203(4): 408-414.
[13]Purysko AS, Remer EM, Coppa CP, et al. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI[J]. AJR, 2012, 198(1): 115-123.
[14]Mohajer K, Frydrychowicz A, Robbins JB, et al. Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid[J]. J Magn Reson Imaging, 2012, 36(3): 686-696.